Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)

Gouzoulis-Mayfrank, Euphrosyne; Daumann, Jörg; Tuchtenhagen, Frank; Pelz, Susanne; Becker, Steffanie; Kunert, Hans-Jürgen; Fimm, Bruno; Sass, Henning
June 2000
Journal of Neurology, Neurosurgery & Psychiatry;Jun2000, p719
Academic Journal
No abstract available.


Related Articles

  • Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance. Parrott, A. C.; Lasky, J. // Psychopharmacology;1998, Vol. 139 Issue 3, p261 

    Abstract Three groups of young people (aged 19-30 years) were compared: 15 regular ecstasy users who had taken MDMA (3,4-methylenedioxymethamphetamine) on ten or more occasions; 15 novice ecstasy users who had taken MDMA on fewer than ten previous occasions; and 15 controls who had never taken...

  • The relative contributions of ecstasy and cannabis to cognitive impairment. Croft, Rodney J.; Mackay, Alex J.; Mills, Alex T.D.; Gruzelier, John G.H. // Psychopharmacology;2001, Vol. 153 Issue 3, p373 

    Abstract Rationale: (+)-3,4-methylenedioxymethamphetamine (MDMA; `ecstasy'), a commonly used recreational drug, has typically been found to be related to poor cognitive function in humans. However, cannabis consumption may not have been adequately controlled for in these studies. Objective: The...

  • Parkinson's disorder, psychomotor problems and dopaminergic neurotoxicity in recreational ecstasy/MDMA users. Parrott, A. C.; Buchanan, T.; Heffernan, T. M.; Scholey, A.; Ling, J.; Rodgers, J. // Psychopharmacology;2003, Vol. 167 Issue 4, p449 

    Studies the implications of recreational 3,4-Methylenedioxy Methamphetamine (MDMA)-induced dopaminergic neurotoxicity in human users of the drug. Clinical manifestations of dopaminergic neurotoxin; Problems associated with MDMA-induced ecstasy; Psychomotor functioning of drug-free MDMA-induced...

  • Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence? Morgan, J.; McFie, L.; Fleetwood, H.; Robinson, A. // Psychopharmacology;2002, Vol. 159 Issue 3, p294 

    Rationale: Chronic, regular recreational use of ecstasy (MDMA) is associated with psychopathology, elevated behavioural impulsivity and persistent impairment of memory performance. Objective: The aim of the present study was to investigate which of these sequelae persist after at least 6 months...

  • Auditory event-related potentials (P3) and cognitive performance in recreational ecstasy polydrug users: evidence from a 12-month longitudinal study. Sola, Susana; Tarancón, Thais; Peña-Casanova, Jordi; Espadaler, Josep; Langohr, Klaus; Poudevida, Sandra; Farré, Magí; Verdejo-García, Antonio; Torre, Rafael // Psychopharmacology;Oct2008, Vol. 200 Issue 3, p425 

    There is important preclinical evidence of the long-lasting neurotoxic and selective effects of ecstasy (MDMA) on serotonin systems in nonhuman primates. In humans, long-term recreational use of ecstasy has been mainly associated with memory impairment. The first aim of our study was to evaluate...

  • Elevated impulsivity and impaired decision-making cognition in heavy users of MDMA (“Ecstasy”). Quednow, Boris B.; Kühn, Kai-Uwe; Hoppe, Christian; Westheide, Jens; Maier, Wolfgang; Daum, Irene; Wagner, Michael // Psychopharmacology;Jan2007, Vol. 189 Issue 4, p517 

    In animal studies, the common club drug 3,4-methylendioxymethamphetamine (MDMA, “Ecstasy”) consistently caused a prolonged loss of presynaptic serotonergic neurons, and evidence suggests that MDMA consumption may also affect the human serotonergic system. Serotonin (5-HT) has been...

  • Cognitive performance and serotonergic function in users of ecstasy. Verkes, Robbert J.; Gijsman, Harm J.; Pieters, Monique S.M.; Schoemaker, Rik C.; de Visser, Saco; Kuijpers, Monique; Pennings, Ed J.M.; de Bruin, Dick; Van de Wijngaart, Govert; Van Gerven, Joop M.A.; Cohen, Adam F. // Psychopharmacology;2001, Vol. 153 Issue 2, p196 

    Abstract Rationale: (+/-) 3,4-Methylenedioxymethamphetamine (MDMA or "ecstasy") has been shown to cause long term damage to serotonergic cerebral neurons in animals. The neurotoxic effects in humans are less clear and little is known about the functional consequences, although some studies...

  • Event related potential (ERP) evidence for selective impairment of verbal recollection in abstinent recreational methylenedioxymethamphetamine ('Ecstasy')/polydrug users. Burgess, Adrian; Venables, Louise; Jones, Helena; Edwards, Rhiannon; Parrott, Andrew // Psychopharmacology;Aug2011, Vol. 216 Issue 4, p545 

    Objectives: Ecstasy is a recreational drug whose active ingredient, 3,4-methylenedioxymethamphetamine (MDMA), acts predominantly on the serotonergic system. Although MDMA is known to be neurotoxic in animals, the long-term effects of recreational Ecstasy use in humans remain controversial but...

  • Neuropsychological function in ecstasy users: a study controlling for polydrug use. Roiser, Jonathan P.; Rogers, Robert D.; Sahakian, Barbara J. // Psychopharmacology;Jan2007, Vol. 189 Issue 4, p505 

    A number of studies have compared ecstasy users to control groups on various measures of neuropsychological function in order to determine whether ecstasy use results in lasting cognitive deficits. However, few of those studies controlled adequately for non-ecstasy illicit drug use. The aim of...

  • Impaired perception of self-motion (heading) in abstinent ecstasy and marijuana users. Rizzo, M.; Lamers, C. T. J.; Sauer, C. G.; Ramaekers, J. G.; Bechara, A.; Andersen, G. J. // Psychopharmacology;May2005, Vol. 179 Issue 3, p559 

    Rationale: Illicit drug use can increase driver crash risk due to loss of control over vehicle trajectory. This study asks, does recreational use of &plusm;3,4-Methylene-dioxymethamphetamine (MDMA; ecstasy) and tetrahydro-cannabinol (THC; marijuana) impair cognitive processes that help direct...


Read the Article


Sign out of this library

Other Topics